nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—RNASE3—hematopoietic system—thymus cancer	0.0493	0.089	CbGeAlD
Pranlukast—IL5—hematopoietic system—thymus cancer	0.0448	0.0808	CbGeAlD
Pranlukast—IL5—epithelium—thymus cancer	0.0409	0.0739	CbGeAlD
Pranlukast—RNASE3—lymphoid tissue—thymus cancer	0.0347	0.0627	CbGeAlD
Pranlukast—RNASE3—bone marrow—thymus cancer	0.0316	0.0571	CbGeAlD
Pranlukast—IL5—lymphoid tissue—thymus cancer	0.0315	0.0569	CbGeAlD
Pranlukast—MUC2—epithelium—thymus cancer	0.0315	0.0568	CbGeAlD
Pranlukast—RNASE3—lung—thymus cancer	0.0286	0.0517	CbGeAlD
Pranlukast—IL5—lung—thymus cancer	0.026	0.047	CbGeAlD
Pranlukast—MUC2—lung—thymus cancer	0.02	0.0361	CbGeAlD
Pranlukast—NFKB1—Canonical NF-kappaB pathway—CYLD—thymus cancer	0.0198	0.0444	CbGpPWpGaD
Pranlukast—NFKB1—hematopoietic system—thymus cancer	0.0196	0.0354	CbGeAlD
Pranlukast—CYSLTR1—hematopoietic system—thymus cancer	0.0193	0.0348	CbGeAlD
Pranlukast—IL5—lymph node—thymus cancer	0.0178	0.0321	CbGeAlD
Pranlukast—TNF—Canonical NF-kappaB pathway—CYLD—thymus cancer	0.0151	0.0339	CbGpPWpGaD
Pranlukast—NFKB1—cardiac atrium—thymus cancer	0.0149	0.0269	CbGeAlD
Pranlukast—NFKB1—pituitary gland—thymus cancer	0.0146	0.0263	CbGeAlD
Pranlukast—NFKB1—lymphoid tissue—thymus cancer	0.0138	0.025	CbGeAlD
Pranlukast—TNF—lymph node—thymus cancer	0.0137	0.0247	CbGeAlD
Pranlukast—CYSLTR1—lymphoid tissue—thymus cancer	0.0136	0.0245	CbGeAlD
Pranlukast—NFKB1—bone marrow—thymus cancer	0.0126	0.0227	CbGeAlD
Pranlukast—NFKB1—thyroid gland—thymus cancer	0.0126	0.0227	CbGeAlD
Pranlukast—CYSLTR1—bone marrow—thymus cancer	0.0124	0.0223	CbGeAlD
Pranlukast—IL5—Cytokines and Inflammatory Response—CD4—thymus cancer	0.012	0.027	CbGpPWpGaD
Pranlukast—NFKB1—lung—thymus cancer	0.0114	0.0206	CbGeAlD
Pranlukast—NFKB1—TNF receptor signaling pathway —CYLD—thymus cancer	0.0114	0.0255	CbGpPWpGaD
Pranlukast—CYSLTR1—lung—thymus cancer	0.0112	0.0202	CbGeAlD
Pranlukast—IL5—Cytokines and Inflammatory Response—IL2—thymus cancer	0.0111	0.0248	CbGpPWpGaD
Pranlukast—IL5—Interleukin receptor SHC signaling—IL2—thymus cancer	0.0108	0.0241	CbGpPWpGaD
Pranlukast—NFKB1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CYLD—thymus cancer	0.0106	0.0239	CbGpPWpGaD
Pranlukast—IL5—Inflammatory Response Pathway—IL2—thymus cancer	0.0102	0.0228	CbGpPWpGaD
Pranlukast—TNF—TNF receptor signaling pathway —CYLD—thymus cancer	0.00867	0.0194	CbGpPWpGaD
Pranlukast—NFKB1—T-Cell Receptor and Co-stimulatory Signaling—CD8A—thymus cancer	0.00804	0.018	CbGpPWpGaD
Pranlukast—NFKB1—lymph node—thymus cancer	0.0078	0.0141	CbGeAlD
Pranlukast—CYSLTR1—lymph node—thymus cancer	0.00766	0.0138	CbGeAlD
Pranlukast—IL5—Interleukin-3, 5 and GM-CSF signaling—IL2—thymus cancer	0.00749	0.0168	CbGpPWpGaD
Pranlukast—NFKB1—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—CYLD—thymus cancer	0.00731	0.0164	CbGpPWpGaD
Pranlukast—NFKB1—Notch Signaling Pathway—MAML2—thymus cancer	0.00722	0.0162	CbGpPWpGaD
Pranlukast—IL5—Interleukin-2 signaling—IL2—thymus cancer	0.00711	0.0159	CbGpPWpGaD
Pranlukast—IL5—G beta:gamma signalling through PI3Kgamma—IL2—thymus cancer	0.00699	0.0157	CbGpPWpGaD
Pranlukast—IL5—GPVI-mediated activation cascade—IL2—thymus cancer	0.00687	0.0154	CbGpPWpGaD
Pranlukast—IL5—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—thymus cancer	0.00676	0.0152	CbGpPWpGaD
Pranlukast—IL5—G-protein beta:gamma signalling—IL2—thymus cancer	0.00666	0.0149	CbGpPWpGaD
Pranlukast—NFKB1—TFs Regulate miRNAs related to cardiac hypertrophy—AKT1—thymus cancer	0.00646	0.0145	CbGpPWpGaD
Pranlukast—IL5—AP-1 transcription factor network—CDKN2A—thymus cancer	0.00596	0.0134	CbGpPWpGaD
Pranlukast—IL5—AP-1 transcription factor network—IL2—thymus cancer	0.00517	0.0116	CbGpPWpGaD
Pranlukast—CYP2C9—hematopoietic system—thymus cancer	0.00514	0.00927	CbGeAlD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—CYLD—thymus cancer	0.0047	0.0105	CbGpPWpGaD
Pranlukast—IL5—Allograft Rejection—IL2—thymus cancer	0.00469	0.0105	CbGpPWpGaD
Pranlukast—IL5—Glucocorticoid receptor regulatory network—IL2—thymus cancer	0.00455	0.0102	CbGpPWpGaD
Pranlukast—NFKB1—IL12-mediated signaling events—CD8A—thymus cancer	0.0045	0.0101	CbGpPWpGaD
Pranlukast—NFKB1—T-Cell Receptor and Co-stimulatory Signaling—IL2—thymus cancer	0.00425	0.00953	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—DPYSL5—thymus cancer	0.0041	0.0092	CbGpPWpGaD
Pranlukast—CYP3A4—hematopoietic system—thymus cancer	0.00392	0.00707	CbGeAlD
Pranlukast—NFKB1—IL23-mediated signaling events—CD4—thymus cancer	0.0038	0.00852	CbGpPWpGaD
Pranlukast—IL5—G beta:gamma signalling through PI3Kgamma—AKT1—thymus cancer	0.00379	0.0085	CbGpPWpGaD
Pranlukast—IL5—GPVI-mediated activation cascade—AKT1—thymus cancer	0.00373	0.00836	CbGpPWpGaD
Pranlukast—TNF—Cytokines and Inflammatory Response—CD4—thymus cancer	0.00373	0.00835	CbGpPWpGaD
Pranlukast—IL5—Signaling by Interleukins—IL2—thymus cancer	0.00365	0.00819	CbGpPWpGaD
Pranlukast—IL5—G-protein beta:gamma signalling—AKT1—thymus cancer	0.00361	0.00809	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—CYLD—thymus cancer	0.00358	0.00803	CbGpPWpGaD
Pranlukast—TNF—IL27-mediated signaling events—IL2—thymus cancer	0.00353	0.00792	CbGpPWpGaD
Pranlukast—NFKB1—Downstream TCR signaling—CD4—thymus cancer	0.0035	0.00785	CbGpPWpGaD
Pranlukast—NFKB1—IL2 signaling events mediated by PI3K—IL2—thymus cancer	0.0035	0.00784	CbGpPWpGaD
Pranlukast—NFKB1—IL23-mediated signaling events—IL2—thymus cancer	0.0035	0.00784	CbGpPWpGaD
Pranlukast—TNF—Cytokines and Inflammatory Response—IL2—thymus cancer	0.00343	0.00769	CbGpPWpGaD
Pranlukast—IL5—AP-1 transcription factor network—TP53—thymus cancer	0.00332	0.00744	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—CD8A—thymus cancer	0.00325	0.00729	CbGpPWpGaD
Pranlukast—TNF—Downstream signaling in naïve CD8+ T cells—CD8A—thymus cancer	0.00317	0.00711	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—DPYSL5—thymus cancer	0.00313	0.00701	CbGpPWpGaD
Pranlukast—IL5—IL4-mediated signaling events—AKT1—thymus cancer	0.00309	0.00692	CbGpPWpGaD
Pranlukast—ABCC2—lymph node—thymus cancer	0.00306	0.00553	CbGeAlD
Pranlukast—IL5—Glucocorticoid receptor regulatory network—TP53—thymus cancer	0.00292	0.00656	CbGpPWpGaD
Pranlukast—TNF—IL23-mediated signaling events—CD4—thymus cancer	0.0029	0.00649	CbGpPWpGaD
Pranlukast—NFKB1—Estrogen signaling pathway—AKT1—thymus cancer	0.00277	0.00622	CbGpPWpGaD
Pranlukast—TNF—IL23-mediated signaling events—IL2—thymus cancer	0.00266	0.00597	CbGpPWpGaD
Pranlukast—NFKB1—TCR signaling—CD4—thymus cancer	0.00262	0.00587	CbGpPWpGaD
Pranlukast—NFKB1—IL12-mediated signaling events—CD4—thymus cancer	0.00258	0.00579	CbGpPWpGaD
Pranlukast—IL5—Regulation of nuclear SMAD2/3 signaling—AKT1—thymus cancer	0.00249	0.00559	CbGpPWpGaD
Pranlukast—IL5—Glucocorticoid receptor regulatory network—AKT1—thymus cancer	0.00247	0.00554	CbGpPWpGaD
Pranlukast—NFKB1—IL12-mediated signaling events—IL2—thymus cancer	0.00238	0.00533	CbGpPWpGaD
Pranlukast—NFKB1—T-Cell Receptor and Co-stimulatory Signaling—AKT1—thymus cancer	0.0023	0.00517	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor Pathway—IL2—thymus cancer	0.00224	0.00502	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—IL2—thymus cancer	0.0022	0.00493	CbGpPWpGaD
Pranlukast—CYSLTR1—Endothelins—AKT1—thymus cancer	0.00219	0.00491	CbGpPWpGaD
Pranlukast—NFKB1—IL17 signaling pathway—AKT1—thymus cancer	0.00218	0.0049	CbGpPWpGaD
Pranlukast—IL5—Immune System—CYLD—thymus cancer	0.00216	0.00484	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of Telomerase—IL2—thymus cancer	0.00215	0.00482	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—CDKN2A—thymus cancer	0.00209	0.0047	CbGpPWpGaD
Pranlukast—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—thymus cancer	0.00209	0.00469	CbGpPWpGaD
Pranlukast—IL5—Platelet activation, signaling and aggregation—IL2—thymus cancer	0.00206	0.00462	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis Modulation and Signaling—CDKN2A—thymus cancer	0.00196	0.0044	CbGpPWpGaD
Pranlukast—NFKB1—CD40/CD40L signaling—AKT1—thymus cancer	0.00194	0.00435	CbGpPWpGaD
Pranlukast—NFKB1—IL2 signaling events mediated by PI3K—AKT1—thymus cancer	0.0019	0.00425	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—CD4—thymus cancer	0.00187	0.00418	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—IL2—thymus cancer	0.00185	0.00415	CbGpPWpGaD
Pranlukast—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—CDKN2A—thymus cancer	0.00175	0.00393	CbGpPWpGaD
Pranlukast—NFKB1—TWEAK Signaling Pathway—AKT1—thymus cancer	0.00171	0.00384	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—IL2—thymus cancer	0.0017	0.00382	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—CDKN2A—thymus cancer	0.0017	0.00381	CbGpPWpGaD
Pranlukast—NFKB1—Corticotropin-releasing hormone—IL2—thymus cancer	0.00169	0.00378	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—IL2—thymus cancer	0.00168	0.00376	CbGpPWpGaD
Pranlukast—TNF—Downstream signaling in naïve CD8+ T cells—IL2—thymus cancer	0.00168	0.00376	CbGpPWpGaD
Pranlukast—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—thymus cancer	0.00167	0.00376	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—CDKN2A—thymus cancer	0.0016	0.00358	CbGpPWpGaD
Pranlukast—NFKB1—TSLP Signaling Pathway—AKT1—thymus cancer	0.00157	0.00351	CbGpPWpGaD
Pranlukast—NFKB1—Ceramide signaling pathway—AKT1—thymus cancer	0.00154	0.00345	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CYLD—thymus cancer	0.00151	0.00337	CbGpPWpGaD
Pranlukast—NFKB1—Angiopoietin receptor Tie2-mediated signaling—AKT1—thymus cancer	0.00149	0.00334	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—KIT—thymus cancer	0.00149	0.00334	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—IL2—thymus cancer	0.00148	0.00333	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—IL2—thymus cancer	0.00145	0.00326	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—TP53—thymus cancer	0.00143	0.00321	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis-related network due to altered Notch3 in ovarian cancer—AKT1—thymus cancer	0.00142	0.00319	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—KIT—thymus cancer	0.00142	0.00319	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—TP53—thymus cancer	0.00141	0.00317	CbGpPWpGaD
Pranlukast—NFKB1—IL-4 Signaling Pathway—AKT1—thymus cancer	0.0014	0.00314	CbGpPWpGaD
Pranlukast—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—TP53—thymus cancer	0.0014	0.00313	CbGpPWpGaD
Pranlukast—NFKB1—RANKL/RANK Signaling Pathway—AKT1—thymus cancer	0.00138	0.0031	CbGpPWpGaD
Pranlukast—NFKB1—Cardiac Hypertrophic Response—AKT1—thymus cancer	0.00138	0.0031	CbGpPWpGaD
Pranlukast—NFKB1—IL-1 signaling pathway—AKT1—thymus cancer	0.00138	0.0031	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—KIT—thymus cancer	0.00131	0.00295	CbGpPWpGaD
Pranlukast—TNF—TWEAK Signaling Pathway—AKT1—thymus cancer	0.00131	0.00293	CbGpPWpGaD
Pranlukast—NFKB1—Notch Signaling Pathway—AKT1—thymus cancer	0.00127	0.00285	CbGpPWpGaD
Pranlukast—NFKB1—Fc-epsilon receptor I signaling in mast cells—AKT1—thymus cancer	0.00127	0.00285	CbGpPWpGaD
Pranlukast—NFKB1—LPA receptor mediated events—AKT1—thymus cancer	0.00122	0.00274	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—AKT1—thymus cancer	0.00121	0.00271	CbGpPWpGaD
Pranlukast—NFKB1—AGE/RAGE pathway—AKT1—thymus cancer	0.00119	0.00268	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—TP53—thymus cancer	0.00119	0.00266	CbGpPWpGaD
Pranlukast—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—AKT1—thymus cancer	0.00118	0.00264	CbGpPWpGaD
Pranlukast—NFKB1—BCR signaling pathway—AKT1—thymus cancer	0.00118	0.00264	CbGpPWpGaD
Pranlukast—TNF—Ceramide signaling pathway—AKT1—thymus cancer	0.00117	0.00263	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—TP53—thymus cancer	0.00117	0.00261	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of Telomerase—AKT1—thymus cancer	0.00117	0.00261	CbGpPWpGaD
Pranlukast—TNF—Angiopoietin receptor Tie2-mediated signaling—AKT1—thymus cancer	0.00114	0.00255	CbGpPWpGaD
Pranlukast—IL5—Platelet activation, signaling and aggregation—AKT1—thymus cancer	0.00112	0.0025	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—CDKN2A—thymus cancer	0.00111	0.00249	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MAML2—thymus cancer	0.00111	0.00248	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis Modulation and Signaling—TP53—thymus cancer	0.00109	0.00245	CbGpPWpGaD
Pranlukast—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—AKT1—thymus cancer	0.00108	0.00243	CbGpPWpGaD
Pranlukast—NFKB1—Leptin signaling pathway—AKT1—thymus cancer	0.00108	0.00242	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—TP53—thymus cancer	0.00108	0.00241	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—IL2—thymus cancer	0.00106	0.00238	CbGpPWpGaD
Pranlukast—IL5—Immune System—CD8A—thymus cancer	0.00105	0.00236	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL2—thymus cancer	0.00105	0.00236	CbGpPWpGaD
Pranlukast—TNF—Cardiac Hypertrophic Response—AKT1—thymus cancer	0.00105	0.00236	CbGpPWpGaD
Pranlukast—TNF—Caspase Cascade in Apoptosis—AKT1—thymus cancer	0.00102	0.00229	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—AKT1—thymus cancer	0.001	0.00225	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—AKT1—thymus cancer	0.000984	0.00221	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—AKT1—thymus cancer	0.000984	0.00221	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—KIT—thymus cancer	0.000968	0.00217	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—TP53—thymus cancer	0.000946	0.00212	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—TP53—thymus cancer	0.000933	0.00209	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—AKT1—thymus cancer	0.000931	0.00209	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—AKT1—thymus cancer	0.000915	0.00205	CbGpPWpGaD
Pranlukast—NFKB1—Corticotropin-releasing hormone—AKT1—thymus cancer	0.000915	0.00205	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—thymus cancer	0.000888	0.00199	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Receptor Signaling Pathway—AKT1—thymus cancer	0.000877	0.00197	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CYLD—thymus cancer	0.000877	0.00197	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—AKT1—thymus cancer	0.000843	0.00189	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CDKN2A—thymus cancer	0.000838	0.00188	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—AKT1—thymus cancer	0.000799	0.00179	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MAML2—thymus cancer	0.000795	0.00178	CbGpPWpGaD
Pranlukast—IL5—Immune System—KIT—thymus cancer	0.000791	0.00177	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—AKT1—thymus cancer	0.00075	0.00168	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—AKT1—thymus cancer	0.00075	0.00168	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—TP53—thymus cancer	0.000729	0.00163	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD8A—thymus cancer	0.000706	0.00158	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—AKT1—thymus cancer	0.000697	0.00156	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL2—thymus cancer	0.000693	0.00155	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TP53—thymus cancer	0.000682	0.00153	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TP53—thymus cancer	0.000677	0.00152	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—IL2—thymus cancer	0.000671	0.0015	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TP53—thymus cancer	0.000669	0.0015	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—AKT1—thymus cancer	0.000658	0.00147	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—AKT1—thymus cancer	0.000642	0.00144	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—AKT1—thymus cancer	0.000639	0.00143	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—TP53—thymus cancer	0.000617	0.00138	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—AKT1—thymus cancer	0.000616	0.00138	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—IL2—thymus cancer	0.000609	0.00137	CbGpPWpGaD
Pranlukast—IL5—Immune System—CD4—thymus cancer	0.000605	0.00136	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	0.000604	0.00135	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—AKT1—thymus cancer	0.000576	0.00129	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thymus cancer	0.000568	0.00127	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—AKT1—thymus cancer	0.000565	0.00127	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL2—thymus cancer	0.000557	0.00125	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—KIT—thymus cancer	0.000552	0.00124	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—thymus cancer	0.000544	0.00122	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	0.000542	0.00122	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—KIT—thymus cancer	0.00053	0.00119	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—KIT—thymus cancer	0.000512	0.00115	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	0.00051	0.00114	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TP53—thymus cancer	0.00051	0.00114	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—AKT1—thymus cancer	0.000502	0.00112	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—AKT1—thymus cancer	0.000501	0.00112	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—IL2—thymus cancer	0.000482	0.00108	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—TP53—thymus cancer	0.000466	0.00105	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	0.00046	0.00103	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—AKT1—thymus cancer	0.000459	0.00103	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MAML2—thymus cancer	0.00045	0.00101	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL2—thymus cancer	0.000437	0.000981	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—AKT1—thymus cancer	0.000431	0.000966	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD8A—thymus cancer	0.000428	0.00096	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CD4—thymus cancer	0.000422	0.000947	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD4—thymus cancer	0.000405	0.000909	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	0.000389	0.000871	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—AKT1—thymus cancer	0.000369	0.000828	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—KIT—thymus cancer	0.000367	0.000823	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—AKT1—thymus cancer	0.000364	0.000816	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL2—thymus cancer	0.00036	0.000807	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—AKT1—thymus cancer	0.00033	0.000741	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—KIT—thymus cancer	0.000322	0.000721	CbGpPWpGaD
Pranlukast—IL5—Immune System—AKT1—thymus cancer	0.000302	0.000677	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—AKT1—thymus cancer	0.000261	0.000585	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL2—thymus cancer	0.000258	0.000579	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD4—thymus cancer	0.000246	0.000551	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—AKT1—thymus cancer	0.000238	0.000535	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—AKT1—thymus cancer	0.000237	0.000532	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TP53—thymus cancer	0.000231	0.000518	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL2—thymus cancer	0.000226	0.000507	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—AKT1—thymus cancer	0.000211	0.000472	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—KIT—thymus cancer	0.000208	0.000466	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—AKT1—thymus cancer	0.000202	0.000453	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—AKT1—thymus cancer	0.000195	0.000438	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—AKT1—thymus cancer	0.000182	0.000407	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TP53—thymus cancer	0.000166	0.000372	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL2—thymus cancer	0.000146	0.000328	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—AKT1—thymus cancer	0.00014	0.000314	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—AKT1—thymus cancer	0.000123	0.000275	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TP53—thymus cancer	9.39e-05	0.000211	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AKT1—thymus cancer	7.93e-05	0.000178	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—AKT1—thymus cancer	2.96e-05	6.64e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AKT1—thymus cancer	1.95e-05	4.38e-05	CbGpPWpGaD
